As a resource to visitors of the Alzheimer Europe Website, we videos of the plenary presentations and symposia at the Alzheimer Europe Conference in Barcelona.

Videos from the following speakers are included:

Welcome and introductory comments by

• Iva Holmerová, Chairperson, Alzheimer Europe
• Cheles Cantabrana, Chairperson, CEAFA
• Santiago Marimón Suñol (Spain)
• Gemma Tarafa, Commissioner for Health, Barcelona City Council

Plenary sessions:

• Meet the researchers of tomorrow: Anja Leist (Luxembourg): Policy and research priorities of the WYLD (World Young Leaders in Dementia) network
• Carmen Orte (Spain): Dementia as a health and social priority in Spain
• Geoff Huggins (United Kingdom): The European Joint Action on Dementia: Identifying and sharing good practices across Europe
• Dan Chisholm (WHO Europe): Prioritising dementia internationally - The WHO Global Action Plan on Dementia and the Global Dementia Observatory
• John Gallacher (United Kingdom): Real world data supporting regulatory and health technology assessments: the findings of the ROADMAP project
• Meet the researchers of tomorrow: Stina Saunders (United Kingdom): Involving research participants in research: The example of the EPAD (European Prevention of Alzheimer’s dementia) project
• Helen Rochford-Brennan (Ireland): Promoting a human rights based approach to dementia through the active involvement of people with dementia
• Fernando Vicente (Spain): Human rights in Spanish health and social legislation
• Dianne Gove (Luxembourg): Recognising dementia as a disability: ethical considerations and practical recommendations
• Karen Watchman (United Kingdom): Dementia and intellectual disability - Valuing the perspectives of people with intellectual disability
• Meet the researchers of tomorrow: Sébastien Libert (Belgium): Assistive technologies in dementia: Findings of the INDUCT (Interdisciplinary Network for Dementia Using Current Technology) consortium
• Gail Mountain (United Kingdom): Redefining and measuring meaningful outcomes for people with dementia
• Manuel Martín Carrasco (Spain): Reducing the use of antipsychotics in residential and nursing homes
• Martina Roes (Germany): Fostering and sustaining relationships with people with dementia
• Meet the researchers of tomorrow: Isadora Alves Lopes (Netherlands): The AMYPAD (Amyloid imaging to prevent Alzheimer’s disease) project: Improving our understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging
• María Isabel González Ingelmo (Spain): Importance of social and health care research in the field of Alzheimer’s disease and other dementias
• Mercè Boada (Spain): Improving the diagnosis of Alzheimer’s disease through EU research collaborations
• Philippe Amouyel (France): Genetics of Alzheimer’s disease, a state-of-play

Special Symposia:

• Mercè Boada (Spain): MOPEAD
• Octavio Rodríguez Gómez (Spain): MOPEAD
• Adrián Rodrigo Salas (Spain): MOPEAD
• Octavio Rodríguez Gómez (Spain) (2): MOPEAD
• Andreea Ciudin (Spain): MOPEAD
• Annette Dumas (Belgium): MOPEAD
• Petri Lampinen (Finland): The experience of receiving a diagnosis of frontotemporal dementia
• The European Working Group of People With Dementia: I have dementia and life goes on
• Thomas Rune Nielsen (Denmark): The prevalence, assessment and diagnosis of dementia in minority ethnic groups
• Charlotta Plejert (Sweden): Interpreter-mediated dementia assessments of people from minority ethnic groups
• Mohammed Akhlak Rauf (United Kingdom): Working with and involving local minority ethnic groups in the development of intercultural care and support
• Debi Lahav (Israel): Activities and support for people from minority ethnic groups provided by the Alzheimer Association of Israel
• Michal Herz (Israel): Issues surrounding live-in/migrant carers for people with dementia

ROADMAP parallel sessions:

• Claire Tochel (United Kingdom): Outcome definition in ROADMAP
• Christophe Bintener (Luxembourg) and a representative of the EWGPWD: The involvement of the European Working Group of People with Dementia in the outcomes work of ROADMAP
• Michael Smith (United Kingdom): Important outcomes of Alzheimer’s disease from the perspective of people with the disease, their supporters & health professionals
• Tania Dussey (Switzerland): Reflections on ROADMAPs outcome definition work
• Ana Diaz (Luxembourg) and a representative of the EWGPWD: The involvement of the European Working Group of People With Dementia in the ethics work of ROADMAP
• Zuzanna Angehrn (Switzerland): Ethical and social implications of using predictive modelling for Alzheimer´s disease prevention
• Alex Mckeown (United Kingdom): Ethical issues in outcome prioritisation in Alzheimer’s disease treatment
• Diane O’Rourke (United Kingdom): Regulatory and HTA perspectives on real-world data in Alzheimer’s Disease
• Catherine Reed (United Kingdom): Learnings from ROADMAP - what is next?
• Glòria Garcia (Spain): Developing the Data Cube
• Johan van der Lei (Netherlands): Challenges to fill in the Data Cube, differences across data sources
• Antje Hottgenroth (Germany): Industry perspective on use and future development

Closing comments and farewell by:

• Nohemi Martínez Rodriguez, Vice-President, Fundación Alzheimer España
• Cheles Cantabrana, Chairperson, CEAFA
• Iva Holmerová, Chairperson, Alzheimer Europe